215 related articles for article (PubMed ID: 23732954)
1. Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.
Gunderson EW; Kirkpatrick MG; Willing LM; Holstege CP
J Addict Med; 2013; 7(3):153-62. PubMed ID: 23732954
[TBL] [Abstract][Full Text] [Related]
2. Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine.
Gunderson EW; Kirkpatrick MG; Willing LM; Holstege CP
J Addict Med; 2013; 7(3):163-8. PubMed ID: 23732955
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports.
Miotto K; Striebel J; Cho AK; Wang C
Drug Alcohol Depend; 2013 Sep; 132(1-2):1-12. PubMed ID: 23916320
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cathinones: "a khat and mouse game".
Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
[TBL] [Abstract][Full Text] [Related]
5. [Mephedrone: a designer drug of recent use in France].
Debruyne D; Courné MA; Le Boisselier R; Djezzar S; Gérardin M; Boucher A; Karila L; Coquerel A; Mallaret M
Therapie; 2010; 65(6):519-24. PubMed ID: 21176758
[TBL] [Abstract][Full Text] [Related]
6. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
German CL; Fleckenstein AE; Hanson GR
Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
[TBL] [Abstract][Full Text] [Related]
7. Behavioral pharmacology of designer cathinones: a review of the preclinical literature.
Gregg RA; Rawls SM
Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
Spiller HA; Ryan ML; Weston RG; Jansen J
Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061
[TBL] [Abstract][Full Text] [Related]
9. A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers.
Warrick BJ; Hill M; Hekman K; Christensen R; Goetz R; Casavant MJ; Wahl M; Mowry JB; Spiller H; Anderson D; Aleguas A; Gummin D; Thomas R; Nezlek C; Smolinske S
Ann Emerg Med; 2013 Sep; 62(3):244-51. PubMed ID: 23540815
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
Coppola M; Mondola R
Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
[TBL] [Abstract][Full Text] [Related]
11. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
Coppola M; Mondola R
Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
[TBL] [Abstract][Full Text] [Related]
12. Awash in a sea of 'bath salts': implications for biomedical research and public health.
Baumann MH
Addiction; 2014 Oct; 109(10):1577-9. PubMed ID: 24984975
[No Abstract] [Full Text] [Related]
13. Psychoactive "bath salts": not so soothing.
Baumann MH; Partilla JS; Lehner KR
Eur J Pharmacol; 2013 Jan; 698(1-3):1-5. PubMed ID: 23178799
[TBL] [Abstract][Full Text] [Related]
14. Bath salts: they are not what you think.
Wieland DM; Halter MJ; Levine C
J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):17-21. PubMed ID: 22439144
[TBL] [Abstract][Full Text] [Related]
15. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.
Ross EA; Reisfield GM; Watson MC; Chronister CW; Goldberger BA
Am J Med; 2012 Sep; 125(9):854-8. PubMed ID: 22682791
[TBL] [Abstract][Full Text] [Related]
16. Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.
McElrath K; O'Neill C
Int J Drug Policy; 2011 Mar; 22(2):120-7. PubMed ID: 21242082
[TBL] [Abstract][Full Text] [Related]
17. Seizures associated with synthetic cathinone exposures in the pediatric population.
Tekulve K; Alexander A; Tormoehlen L
Pediatr Neurol; 2014 Jul; 51(1):67-70. PubMed ID: 24814056
[TBL] [Abstract][Full Text] [Related]
18. Synthetic cathinones (bath salts): legal status and patterns of abuse.
Fass JA; Fass AD; Garcia AS
Ann Pharmacother; 2012 Mar; 46(3):436-41. PubMed ID: 22388331
[TBL] [Abstract][Full Text] [Related]
19. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
[TBL] [Abstract][Full Text] [Related]
20. "Bath salts" and "plant food" products: the experience of one regional US poison center.
Murphy CM; Dulaney AR; Beuhler MC; Kacinko S
J Med Toxicol; 2013 Mar; 9(1):42-8. PubMed ID: 22733603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
